Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study (TEA-ACLF)

Shanghai Jiao Tong University

Status: Unknown

Conditions: Acute-On-Chronic Liver Failure; Liver Transplant; Complications; Liver Cirrhosis

Study type: Observational

Funder types: Other

Identifiers

NCT05036031

Renji-IIT2021091

Details and patient eligibility

About

The definition and diagnostic criteria of acute-on chronic liver failure (ACLF) differed evidently between the East and the West due to the difference in the underlying etiology. Liver transplantation is the most effective treatment to reverse the progress of ACLF and improve the survival rate of patients. The purpose of this study is to explore the accuracy of the two diagnostic criteria of EASL-CLIF and APASL ACLF in assessing the survival rate of patients with liver cirrhosis after LT.

Full description

A retrospective collection and analysis of the preoperative conditions of patients with LT due to cirrhosis in a single center from January 2015 to June 2020 would be conducted, including epidemiological characteristics, etiology, clinical indicators, and short-term (28 days, 90 days) and long-term (1 year, 3 years) survival after LT.

Enrollment: 500 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients underwent liver transplantation for cirrhosis
• The diagnosis of ACLF followed APASL and EASL-CLIF definition.

Exclusion criteria

• Patients with malignant tumor or underwent living donor liver transplantation (LDLT) were excluded.

Trial design

500 participants in 3 patient groups

EASL-CLIF ACLF patients

APASL ACLF patients

Non-ACLF patients